Abstract
P3.02b-115 Clinical Activity of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer (NSCLC) Patients (Pts) Previously Treated with Rociletinib: Topic: EGFR RES
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have